10-K Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 FY 2015

Filing Information

Form Type	10-K
Accession Number	`0001213900-15-006928`
Period End Date	20150630
Filing Date	20150911
Fiscal Year	2015
Fiscal Period	FY
XBRL Instance	relm-20150630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 61 Income Statement 33 Cash Flow Statement 120 Stockholders Equity 30

Balance Sheet 61 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.56M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.52M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.77M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.50M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$178.16K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$25.74M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$23.97M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$23.91K	USD	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$9.84K	USD	Point-in-time
Other assets	`OtherAssets`	$400.82K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	8.06M	shares	Point-in-time
Other assets	`OtherAssets`	$12.10K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	10.78M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	8.06M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	10.78M	shares	Point-in-time
Total assets	`Assets`	$24.39M	USD	Point-in-time
Total assets	`Assets`	$25.76M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$835.28K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$746.10K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$482.27K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$382.02K	USD	Point-in-time
Note payable	`NotesPayableCurrent`	$263.75K	USD	Point-in-time
Note payable	`NotesPayableCurrent`	$58.36K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$25.59M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$20.10M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$14.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$26.77M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.58M	USD	Point-in-time
Long-term liability - accrued expense	`AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent`	-	USD	Point-in-time
Long-term liability - accrued expense	`AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent`	$100.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$15.58M	USD	Point-in-time
Total liabilities	`Liabilities`	$26.87M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, value	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, value	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 10,778,474 and 8,058,843 shares issued and outstanding, respectively	`CommonStockValue`	$8.06K	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 10,778,474 and 8,058,843 shares issued and outstanding, respectively	`CommonStockValue`	$10.78K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$54.20M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$84.92M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-76.12M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-55.32M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-17.95M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-1.11M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-3.71M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$8.81M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$24.39M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$25.76M	USD	Point-in-time

Income Statement 33 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$839.96K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$5.25M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$7.87M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$12.11M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$9.23M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$1.53M	USD	Annual
Total operating expenses	`OperatingExpenses`	$12.95M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$17.10M	USD	Annual
Total operating expenses	`OperatingExpenses`	$6.77M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-6.77M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-12.95M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-17.10M	USD	Annual
Loss on change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-3.71M	USD	Annual
Loss on change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-7.95M	USD	2 Qtrs
Loss on change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-12.88M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$1.41K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$10.88K	USD	Annual
Interest income	`InvestmentIncomeInterest`	-	USD	Annual
Interest expense	`InterestExpense`	$435.61K	USD	2 Qtrs
Interest expense	`InterestExpense`	$220.31K	USD	Annual
Interest expense	`InterestExpense`	$4.92K	USD	Annual
Total other expenses	`OtherNonoperatingIncomeExpense`	$-8.39M	USD	2 Qtrs
Total other expenses	`OtherNonoperatingIncomeExpense`	$-13.10M	USD	Annual
Total other expenses	`OtherNonoperatingIncomeExpense`	$-3.70M	USD	Annual
Net loss	`NetIncomeLoss`	$-20.80M	USD	Annual
Net loss	`NetIncomeLoss`	$-19.87M	USD	Annual
Net loss	`NetIncomeLoss`	$-21.34M	USD	2 Qtrs
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-40.90	USD	Annual
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-2.09	USD	Annual
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-8.65	USD	2 Qtrs
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.94M	shares	Annual
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.47M	shares	2 Qtrs
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	485,853.00	shares	Annual

Cash Flow Statement 120 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-20.80M	USD	Annual
Net Loss	`NetIncomeLoss`	$-19.87M	USD	Annual
Net Loss	`NetIncomeLoss`	$-21.34M	USD	2 Qtrs
Depreciation expense	`Depreciation`	$9.26K	USD	Annual
Depreciation expense	`Depreciation`	$373.00	USD	Annual
Depreciation expense	`Depreciation`	$2.33K	USD	2 Qtrs
Common stock issued for services	`CommonStockIssuedForServices`	$-8.71K	USD	2 Qtrs
Common stock issued for services	`CommonStockIssuedForServices`	$-3.77M	USD	Annual
Common stock issued for services	`CommonStockIssuedForServices`	$-1.18M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$796.95K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$382.34K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$10.32M	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$118.64K	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$327.78K	USD	2 Qtrs
Amortization of deferred financing costs	`AmortizationOfFinancingCosts`	$69.55K	USD	Annual
Amortization of deferred financing costs	`AmortizationOfFinancingCosts`	-	USD	Annual
Amortization of deferred financing costs	`AmortizationOfFinancingCosts`	$78.72K	USD	2 Qtrs
Loss on change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$7.95M	USD	2 Qtrs
Loss on change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$3.71M	USD	Annual
Loss on change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$12.88M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesOther`	$-160.28K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesOther`	$89.98K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesOther`	$1.21M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$89.19K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-57.10K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$565.78K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$315.70K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$4.29K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$244.00	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.16M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.24M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-16.23M	USD	Annual
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$3.67K	USD	2 Qtrs
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$8.87K	USD	Annual
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$23.33K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-8.87K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-23.33K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.67K	USD	2 Qtrs
Proceeds from sale of Series A preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	-	USD	Annual
Proceeds from sale of Series A preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	-	USD	2 Qtrs
Proceeds from sale of Series A preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	$3.49M	USD	Annual
Proceeds from sale of common stock and warrants, net of fees	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	Annual
Proceeds from sale of common stock and warrants, net of fees	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	Annual
Proceeds from sale of common stock and warrants, net of fees	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$22.23M	USD	2 Qtrs
Proceeds from sale of common and Class A Series A preferred stock, pursuant to Share Exchange	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	Annual
Proceeds from sale of common and Class A Series A preferred stock, pursuant to Share Exchange	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	Annual
Proceeds from sale of common and Class A Series A preferred stock, pursuant to Share Exchange	`ProceedsFromIssuanceOrSaleOfEquity`	$2.00M	USD	2 Qtrs
Proceeds from exercise of A warrants, net of fees	`ProceedsFromWarrantExercises`	-	USD	2 Qtrs
Proceeds from exercise of A warrants, net of fees	`ProceedsFromWarrantExercises`	-	USD	Annual
Proceeds from exercise of A warrants, net of fees	`ProceedsFromWarrantExercises`	$13.42M	USD	Annual
Proceeds from warrant exercises from consultants and Series A preferred stock warrant holder	`ProceedsFromIssuanceOfWarrants`	-	USD	Annual
Proceeds from warrant exercises from consultants and Series A preferred stock warrant holder	`ProceedsFromIssuanceOfWarrants`	-	USD	2 Qtrs
Proceeds from warrant exercises from consultants and Series A preferred stock warrant holder	`ProceedsFromIssuanceOfWarrants`	$25.45K	USD	Annual
Payment of notes payable	`RepaymentsOfNotesPayable`	$19.49K	USD	2 Qtrs
Payment of notes payable	`RepaymentsOfNotesPayable`	-	USD	Annual
Payment of notes payable	`RepaymentsOfNotesPayable`	$293.62K	USD	Annual
Proceeds from subordinated promissory notes payable, net of financing costs	`ProceedsFromSubordinatedPromissoryNotesNetOfDeferredFinancingCosts`	$501.60K	USD	Annual
Proceeds from subordinated promissory notes payable, net of financing costs	`ProceedsFromSubordinatedPromissoryNotesNetOfDeferredFinancingCosts`	-	USD	2 Qtrs
Proceeds from subordinated promissory notes payable, net of financing costs	`ProceedsFromSubordinatedPromissoryNotesNetOfDeferredFinancingCosts`	-	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.00M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$24.21M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$13.16M	USD	Annual
Net (decrease) increase in cash	`CashPeriodIncreaseDecrease`	$22.04M	USD	2 Qtrs
Net (decrease) increase in cash	`CashPeriodIncreaseDecrease`	$-3.09M	USD	Annual
Net (decrease) increase in cash	`CashPeriodIncreaseDecrease`	$1.75M	USD	Annual
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$25.56M	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$3.52M	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$1.77M	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$25.56M	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$3.52M	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$1.77M	USD	Point-in-time
Income taxes	`IncomeTaxesPaid`	-	USD	Annual
Income taxes	`IncomeTaxesPaid`	-	USD	Annual
Income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Interest	`InterestPaid`	$4.92K	USD	Annual
Interest	`InterestPaid`	-	USD	Annual
Interest	`InterestPaid`	$1.10K	USD	2 Qtrs
Conversion of Series A preferred stock and subordinated notes to common stock	`ShareExchangeOfSubordinatedDebt`	$900.00K	USD	2 Qtrs
Conversion of Series A preferred stock and subordinated notes to common stock	`ShareExchangeOfSubordinatedDebt`	-	USD	Annual
Conversion of Series A preferred stock and subordinated notes to common stock	`ShareExchangeOfSubordinatedDebt`	-	USD	Annual
Conversion of accrued interest to common stock	`ShareExchangeOfAccruedInterest`	-	USD	Annual
Conversion of accrued interest to common stock	`ShareExchangeOfAccruedInterest`	$60.92K	USD	2 Qtrs
Conversion of accrued interest to common stock	`ShareExchangeOfAccruedInterest`	-	USD	Annual
Note payable issued in connection with director and officer insurance policies	`IssuanceOfDebtInConnectionWithCompensationPolicy`	-	USD	Annual
Note payable issued in connection with director and officer insurance policies	`IssuanceOfDebtInConnectionWithCompensationPolicy`	$557.38K	USD	Annual
Note payable issued in connection with director and officer insurance policies	`IssuanceOfDebtInConnectionWithCompensationPolicy`	$77.85K	USD	Point-in-time
Note payable issued in connection with director and officer insurance policies	`IssuanceOfDebtInConnectionWithCompensationPolicy`	$77.85K	USD	2 Qtrs
Cancellation of note payable in connection with director and officer insurance policy	`CancellationOfNotePayableInConnectionWithDirectorAndOfficerPolicy`	-	USD	2 Qtrs
Cancellation of note payable in connection with director and officer insurance policy	`CancellationOfNotePayableInConnectionWithDirectorAndOfficerPolicy`	$55.22K	USD	Annual
Cancellation of note payable in connection with director and officer insurance policy	`CancellationOfNotePayableInConnectionWithDirectorAndOfficerPolicy`	-	USD	Annual
Reclassification of derivative liabilities to additional paid-in capital for warrant exercises	`ReclassificationOfWarrantLiabilitiesToAdditionalPaid-InCapitalForDerivativeExercise`	-	USD	2 Qtrs
Reclassification of derivative liabilities to additional paid-in capital for warrant exercises	`ReclassificationOfWarrantLiabilitiesToAdditionalPaid-InCapitalForDerivativeExercise`	-	USD	Annual
Reclassification of derivative liabilities to additional paid-in capital for warrant exercises	`ReclassificationOfWarrantLiabilitiesToAdditionalPaid-InCapitalForDerivativeExercise`	$15.30M	USD	Annual
Fair value of derivative reclassified to additional paid-in-capital in connection with Share Exchange	`FairValueOfDerivativesTerminatedInConnectionWithShareExchange`	$6.80M	USD	2 Qtrs
Fair value of derivative reclassified to additional paid-in-capital in connection with Share Exchange	`FairValueOfDerivativesTerminatedInConnectionWithShareExchange`	-	USD	Annual
Fair value of derivative reclassified to additional paid-in-capital in connection with Share Exchange	`FairValueOfDerivativesTerminatedInConnectionWithShareExchange`	-	USD	Annual
Conversion of Class A preferred stock to common stock	`ConversionOfStockAmountConverted1`	$595.00	USD	Annual
Conversion of Class A preferred stock to common stock	`ConversionOfStockAmountConverted1`	-	USD	2 Qtrs
Conversion of Class A preferred stock to common stock	`ConversionOfStockAmountConverted1`	-	USD	Annual
Fair value of derivative warrants issued with units offering	`FairValueOfDerivativesIssuedInConnectionWithIssuanceOfCommonStock`	-	USD	Annual
Fair value of derivative warrants issued with units offering	`FairValueOfDerivativesIssuedInConnectionWithIssuanceOfCommonStock`	-	USD	Annual
Fair value of derivative warrants issued with units offering	`FairValueOfDerivativesIssuedInConnectionWithIssuanceOfCommonStock`	$4.33M	USD	2 Qtrs
Beneficial conversion feature	`BeneficialConversionFeature`	$186.73K	USD	2 Qtrs
Beneficial conversion feature	`BeneficialConversionFeature`	-	USD	Annual
Beneficial conversion feature	`BeneficialConversionFeature`	-	USD	Annual
Fair value of derivatives issued in connection with issuance of preferred stock	`FairValueOfDerivativesIssuedInConnectionWithIssuanceOfPreferredStock`	-	USD	Annual
Fair value of derivatives issued in connection with issuance of preferred stock	`FairValueOfDerivativesIssuedInConnectionWithIssuanceOfPreferredStock`	-	USD	2 Qtrs
Fair value of derivatives issued in connection with issuance of preferred stock	`FairValueOfDerivativesIssuedInConnectionWithIssuanceOfPreferredStock`	$1.76M	USD	Annual
Fair value of derivative warrants issued to lenders in connection with issuance of subordinated promissory notes	`FairValueOfDerivativeWarrantsIssuedToLendersInConnectionWithIssuanceOfSubordinatedPromissoryNotes`	-	USD	2 Qtrs
Fair value of derivative warrants issued to lenders in connection with issuance of subordinated promissory notes	`FairValueOfDerivativeWarrantsIssuedToLendersInConnectionWithIssuanceOfSubordinatedPromissoryNotes`	$83.36K	USD	Annual
Fair value of derivative warrants issued to lenders in connection with issuance of subordinated promissory notes	`FairValueOfDerivativeWarrantsIssuedToLendersInConnectionWithIssuanceOfSubordinatedPromissoryNotes`	-	USD	Annual
Fair value of warrants issued in connection with deferred financing costs	`FairValueAdjustmentOfWarrants`	-	USD	Annual
Fair value of warrants issued in connection with deferred financing costs	`FairValueAdjustmentOfWarrants`	$41.68K	USD	Annual
Fair value of warrants issued in connection with deferred financing costs	`FairValueAdjustmentOfWarrants`	-	USD	2 Qtrs
Fair value of derivative warrants issued for offering costs in connection with the issuance of Series A preferred stock	`FairValueOfDerivativeWarrantsIssuedForOfferingCostsInConnectionWithTheIssuanceOfSeriesAPreferredStock`	$248.66K	USD	Annual
Fair value of derivative warrants issued for offering costs in connection with the issuance of Series A preferred stock	`FairValueOfDerivativeWarrantsIssuedForOfferingCostsInConnectionWithTheIssuanceOfSeriesAPreferredStock`	-	USD	2 Qtrs
Fair value of derivative warrants issued for offering costs in connection with the issuance of Series A preferred stock	`FairValueOfDerivativeWarrantsIssuedForOfferingCostsInConnectionWithTheIssuanceOfSeriesAPreferredStock`	-	USD	Annual

Stockholders Equity 30 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$-17.95M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$-1.11M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$-3.71M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$8.81M	USD	Point-in-time
Issuance of Series A preferred stock and warrants for cash, net of offering costs	`IssuanceOfSeriesAPreferredStockAndWarrantsForCashNetOfOfferingCostsValue`	$1.48M	USD	Annual
Issuance of common stock, Series A warrants and Series B warrants for cash, net of offering cost	`IssuanceOfCommonStockForSeriesAWarrantsAndSeriesBWarrantsValue`	$22.23M	USD	2 Qtrs
Issuance of common stock to acquire Medeor, Inc. at fair value	`StockIssuedDuringPeriodValueAcquisitions`	$3.75M	USD	Annual
Issuance of common stock to acquire Medeor, Inc. at fair value, Shares	`StockIssuedDuringPeriodSharesAcquisitions`	683.00	shares	Point-in-time
Issuance of common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$16.92K	USD	Annual
Issuance of common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$1.18M	USD	Annual
Issuance of common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$8.71K	USD	2 Qtrs
Issuance of common stock in connection with a warrant exercises	`IssuanceOfCommonStockInConnectionWithAWarrantExercises`	$13.42M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$796.95K	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$382.34K	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$10.32M	USD	2 Qtrs
Fair value of warrant derivative liabilities issued in units offering	`FairValueOfWarrantDerivativeLiabilitiesIssuedInUnitsOffering`	$-4.33M	USD	2 Qtrs
Reclassification of derivative liabilities to additional paid-in capital upon Share Exchange	`IssuanceOfEliminatingDerivativeLiabilitiesUponShareExchangeDuringPeriodValue`	$6.80M	USD	2 Qtrs
Conversion of Series A preferred stock, notes payable and accrued interest to common stock	`SeriesAPreferredStockNotesAndAccruedInterestForCommonStockAutomaticConversionFeatureValue`	$960.92K	USD	2 Qtrs
Issuance of common stock and Class A preferred stock in connection with share exchange	`IssuanceOfCommonStockAndPreferredStockInConnectionWithShareExchange`	$2.00M	USD	2 Qtrs
Beneficial conversion feature	`DebtInstrumentConvertibleBeneficialConversionFeature`	$186.73K	USD	2 Qtrs
Reclassification of derivative liabilities to additional paid-in capital for warrant exercises	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$15.30M	USD	Annual
Issuance of common stock resulting from warrant exercises from consultants and Series A preferred warrant holder	`IssuanceOfCommonStockResultingFromWarrantExercisesFromConsultantsAndSeriesAPreferredWarrantHolder`	$25.45K	USD	Annual
Conversion of Class A preferred stock to common stock	`StockIssuedDuringPeriodValueConversionOfUnits`	-	USD	Annual
Net Loss	`NetIncomeLoss`	$-20.80M	USD	Annual
Net Loss	`NetIncomeLoss`	$-19.87M	USD	Annual
Net Loss	`NetIncomeLoss`	$-21.34M	USD	2 Qtrs
Ending Balance	`StockholdersEquity`	$-17.95M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$-1.11M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$-3.71M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$8.81M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.